ANV-6L15

N/A

Report date: 2025/06/11 11:16:38

Base Information

Drug NameANV-6L15
Drug Alias NameANV-6L15A6L15
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCoagulation factor inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEVAS Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesEVAS Therapeutics
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A